You are here

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Cypress, California, 90630 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Volunteers
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Generally healthy

- BMI of 18-30 kg/m2

- more than 50 kg bodyweight.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Pregnant

- exposure to biologic type drugs within the last 3 months

- history of allergic or anaphylactic reaction to a biologic drug

- use of tobacco- or nicotine containing products that is more than what is in 5
cigarettes per day

- excessive alcohol use.

NCT00788294
Pfizer
Completed
Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now